T409-0472 Screening compound: N-benzyl-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide

T409-0472 Screening compound: N-benzyl-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide
T409-0472 Screening compound: N-benzyl-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T409-0472
N-benzyl-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T409-0472

Molecular Formula

C24H30N4O2S (C24 H30 N4 O2 S)

Compound Name

N-benzyl-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxamide

IUPAC name

N-benzyl-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4567-tetrahydro-13-benzothiazole-6-carboxamide

SMILES

O=C(C1CCC1)N(CC1)CCN1c1nc(CCC(C2)C(NCc3ccccc3)=O)c2s1

InChI

InChI=1S/C24H30N4O2S/c29-22(25-16-17-5-2-1-3-6-17)19-9-10-20-21(15-19)31-24(26-20)28-13-11-27(12-14-28)23(30)18-7-4-8-18/h1-3,5-6,18-19H,4,7-16H2,(H,25,29)/t19-/m1/s1

InChI Key

SAHSIILQGUEYST-LJQANCHMSA-N

MDL Number (MFCD)

MFCD29023891

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

438.59

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.013

Distribution Coefficient, logD

2.907

Water Solubility, LogSw

-3.26

Polar Surface Area

56.325

Acid Dissociation Constant (pKa)

11.95

Base Dissociation Constant (pKb)

6.84

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

54.20

T409-0472 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with T409-0472 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T409-0472?
Check Price and Availability of T409-0472, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T409-0472 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T409-0472
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T409-0472
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T409-0472 available by request